Company Filing History:
Years Active: 2020
Title: Alina Popa: Innovator in Cancer Immunotherapy
Introduction
Alina Popa is a distinguished inventor based in Abingdon, GB. She has made significant contributions to the field of cancer immunotherapy, holding 2 patents that focus on novel peptides and their applications in treating cancer.
Latest Patents
Her latest patents include "Peptides derived from Kita-kyushu lung cancer antigen (KKLC1, CT83, CXorf61) and complexes comprising such peptides bound to MHC molecules." This invention relates to innovative peptides derived from the Kita-kyushu lung cancer antigen (CT83) and complexes that bind these peptides to recombinant MHC molecules. The invention also includes binding moieties that interact with the peptides and complexes, which are valuable for developing immunotherapeutic agents for cancer treatment. Another significant patent is "Peptides derived from actin-like protein 8 (ACTL8)." This invention similarly focuses on novel peptides derived from Actin-like protein 8 and their complexes with recombinant MHC molecules, along with binding moieties that can aid in the development of immunotherapeutic reagents for cancer.
Career Highlights
Alina has worked with notable companies in the biotechnology sector, including Immunocore Limited and Adaptimmune Limited. Her work in these organizations has furthered the development of innovative treatments for cancer, showcasing her commitment to advancing medical science.
Collaborations
Alina has collaborated with professionals such as Alex Powlesland and Chandramouli Reddy Chillakuri, contributing to a dynamic research environment focused on cancer immunotherapy.
Conclusion
Alina Popa's contributions to the field of cancer immunotherapy through her innovative patents and collaborations highlight her role as a leading inventor in this critical area of research. Her work continues to pave the way for new therapeutic approaches to combat cancer.